Percentage of Glycosylated Serum Ferritin Remains Low Throughout the Course of Adult Onset Still's Disease

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 2000 Apr 28

PMID 10784516

Citations 28

Authors

S Vignes

G Le Moel

B Fautrel

B Wechsler

P Godeau

J C Piette

Affiliations

Soon will be listed here.

Abstract

Objective: To determine the evolution of levels of total serum ferritin and percentage of the glycosylated form in patients with adult onset Still's disease (AOSD) at the time of diagnosis and during follow up.

Methods: All patients with AOSD were tested at the time of diagnosis and during follow up. Total serum ferritin levels were analysed by immunoassay, and the percentage of glycosylated ferritin was determined by methods using Sepharose-Con A.

Results: 14 patients (eight women, six men) with AOSD were enrolled. At the time of diagnosis, mean (SD) age was 36 (16) years. Mean initial total serum ferritin was 6350 (1300) microg/l (normal <250 microg/l). The mean initial percentage of glycosylated ferritin was 14.7 (13)% (normal >50%). Mean follow up time was 37 (35) months. At the time of the last examination all patients were in remission except one, who presented a chronic articular form. Total serum ferritin remained high in this single patient and was normal in the 13 others, with a mean of 98 (73) microg/l. In all patients the percentage of glycosylated ferritin remained low, with a mean of 16 (16)%.

Conclusion: Total serum ferritin is a marker of the active phase of AOSD. The percentage of glycosylated ferritin is low both in the active phase and in remission. Further studies are needed to confirm these data and to determine their specificity for AOSD before considering any possible use of a low percentage of glycosylated ferritin as a diagnostic tool in suspected AOSD, especially when atypical or previously treated.

Citing Articles

Update in Hyperferritinemic Syndromes: Recognition and Management - A Scoping Review.

Vassilopoulos A, McCormick W, Lakhani A Brown J Hosp Med. 2025; 1(3):37667.

PMID: 40046595 PMC: 11878877. DOI: 10.56305/001c.37667.

Still's Disease Onset in Older Adults: Clinical Features, Diagnosis, and Management.

Tada Y, Maruyama A, Shirahama Y Drugs Aging. 2024; 41(9):713-724.

PMID: 39097535 DOI: 10.1007/s40266-024-01137-6.

Diagnosis and treatment of adult-onset Still's disease: a concise summary of the German society of rheumatology S2 guideline.

Vordenbaumen S, Feist E, Rech J, Fleck M, Blank N, Haas J Z Rheumatol. 2022; 82(Suppl 2):81-92.

PMID: 36520170 DOI: 10.1007/s00393-022-01294-2.

Evanescent, episodic salmon-colored macules in a young woman.

Leeolou M, Young P, Dear A, Narala S, Saleem A, Rieger K JAAD Case Rep. 2022; 29:30-32.

PMID: 36186409 PMC: 9522868. DOI: 10.1016/j.jdcr.2022.08.022.

Evaluation of Glycosylated Ferritin in Adult-Onset Still's Disease and Differential Diagnoses.

Guerber A, Garneret E, El Jammal T, Zaepfel S, Gerfaud-Valentin M, Seve P J Clin Med. 2022; 11(17).

PMID: 36078942 PMC: 9456550. DOI: 10.3390/jcm11175012.

References

Cazzola M, Borgna-Pignatti C, De Stefano P, Bergamaschi G, Bongo I, Dezza L . Internal distribution of excess iron and sources of serum ferritin in patients with thalassemia. Scand J Haematol. 1983; 30(4):289-96. DOI: 10.1111/j.1600-0609.1983.tb01494.x. View

Debray H, Decout D, Strecker G, SPIK G, Montreuil J . Specificity of twelve lectins towards oligosaccharides and glycopeptides related to N-glycosylproteins. Eur J Biochem. 1981; 117(1):41-55. DOI: 10.1111/j.1432-1033.1981.tb06300.x. View

Ohta A, Yamaguchi M, Kaneoka H, Nagayoshi T, Hiida M . Adult Still's disease: review of 228 cases from the literature. J Rheumatol. 1987; 14(6):1139-46. View

Gonzalez-Hernandez T, Martin-Mola E, de Miguel-Mendieta E . Serum ferritin can be useful for diagnosis in adult onset Still's disease. J Rheumatol. 1989; 16(3):412-3. View

Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H . Preliminary criteria for classification of adult Still's disease. J Rheumatol. 1992; 19(3):424-30. View

Schwarz-Eywill M, Heilig B, Bauer H, Breitbart A, Pezzutto A . Evaluation of serum ferritin as a marker for adult Still's disease activity. Ann Rheum Dis. 1992; 51(5):683-5. PMC: 1005709. DOI: 10.1136/ard.51.5.683. View

Van Reeth C, Le Moel G, Lasne Y, Revenant M, Agneray J, Kahn M . Serum ferritin and isoferritins are tools for diagnosis of active adult Still's disease. J Rheumatol. 1994; 21(5):890-5. View

Higashi S, Ota T, Eto S . Biochemical analysis of ferritin subunits in sera from adult Still's disease patients. Rheumatol Int. 1995; 15(2):45-50. DOI: 10.1007/BF00262707. View

Vignes S, Wechsler B, Amoura Z, Papo T, Frances C, Huong D . Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal anti-inflammatory drugs. Clin Exp Rheumatol. 1998; 16(3):295-8. View

10.

Basset C, Dueymes M, Devauchelle V, Mimassi N, Pennec Y, Youinou P . Changes in glycosylation of immunoglobulins in primary Sjögren's syndrome. Ann Med Interne (Paris). 2001; 149(1):42-4. View

11.

ASHWELL G, Morell A . The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol Relat Areas Mol Biol. 1974; 41(0):99-128. DOI: 10.1002/9780470122860.ch3. View

12.

Arosio P, Adelman T, DRYSDALE J . On ferritin heterogeneity. Further evidence for heteropolymers. J Biol Chem. 1978; 253(12):4451-8. View

13.

Worwood M, Cragg S, Wagstaff M, Jacobs A . Binding of human serum ferritin to concanavalin A. Clin Sci (Lond). 1979; 56(1):83-7. DOI: 10.1042/cs0560083. View

14.

Cragg S, Wagstaff M, Worwood M . Sialic acid and the microheterogeneity of human serum ferritin. Clin Sci (Lond). 1980; 58(3):259-62. DOI: 10.1042/cs0580259. View

15.

Ota T, Higashi S, Suzuki H, Eto S . Increased serum ferritin levels in adult Still's disease. Lancet. 1987; 1(8532):562-3. DOI: 10.1016/s0140-6736(87)90204-2. View